“ By November 2020, four LFD Ag tests were shown to have a sensitivity of over 70% of all RT-PCR positives and, critically, these tests detected almost all (over 95%) with high viral loads (the current infections that are most infectious when tested). Sensitivity was not affected by the presence or absence of symptoms in those tested, although test performance was closely related to the level of training of those conducting the test. Five LFD Ag tests have been shown to detect the new variant of SARS-CoV-2 that became widespread in South-East England and London in December 2020.”
Wonder if we’re one of the 5?
“ LFD antibody tests have also been developed. These indicate whether a person has had infection with COVID-19 at some point in the past and cannot diagnose current infection. A phased evaluation process for LFD antibody POC/NP tests is being established, similar to that for antigen tests.
Both LFD antigen and antibody POC/NP tests should be distinguished from the postal self-sampling kits that are being sent to homes. These self-sampling kits are used by someone to take their specimen and return it to a central laboratory for testing.”
No timescale was set but this was the email I received back on the 18th December
“ Re. 3 – Omega haven’t confirmed the timing of the process but Colin King did say that he hopes to have this completed and available in the early new year and it would be sold under the VISITECT brand”
? Launch Mologic ELISA antibody test service ? Massively scale up Alva production facility ? Ensure Mologic Tech Transfer is on track ? Finish ramping up capacity to 2 million tests a week ? Buy office blinds .....
We welcome @abingdon_health's update re. the AbC-19 Rapid Test, confirming: ?? Expectations for supply arrangements with DHSC ?? Efforts to obtain regulatory approvals in 27 nations ?? Work to build dataset(s) around the AbC-19 use-case alongside #COVID19 vaccines #ODX #ABDX
“ MOSCOW, January 22. /TASS/. People should be tested for COVID-19 antibodies before receiving the vaccine to avoid antigenic overload given they have survived the infection without displaying any symptoms, Alexander Gorelov, the deputy director for science of the Central Research Institute of Epidemiology at the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, said Friday.”